This study was designed to investigate the possible effect of the insulin receptor substrate 1 (IRS1) gene rs1801276 polymorphism on the risk of nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene IRS1 and metabolic dysfunction-associated steatotic liver disease.